Table of Contents
PPT Slide
Forward-Looking Statements
VMS FY03 Profile
VMS Segments & Orders
Oncology Growth Drivers
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
Oncology Systems Products
IMRT: The Advantages
Five-Year Survival Rates For Prostate Cancer
Prostate Cancer: IMRT Lowers Complication Rates
IMRT Adoption Rate
The Radiotherapy Continuum
Dynamic Targeting IGRT Imaging Guided Radiotherapy
Trilogy
PPT Slide
X-Ray Products
Emerging Business Opportunities
Emerging Business Opportunities
FY03
Financial Summary
Backlog Record $808M (As of 9/26/03)
Balance Sheet / Cash Flow (as of 9/26/03)
Fiscal 2004 Outlook
PPT Slide
|